Search
for
Sort by
Research 31–60 of 338
- Cutaneous Drug Eruptions Associated with the Use of Biologies and Cutaneous Drug Eruptions Mimicking Specific Skin Diseases
- Atlas of Geriatric Dermatology
- Acne and acneiform eruptions
- Chemotherapy and the Skin: Understanding Dermatologic Side Effects
- Oral Spironolactone for Acne Vulgaris in Adult Females: A Hybrid Systematic Review
- Proceedings of the Heinz Maurer-Symposium “Review and Preview in Science for Healthy Skin” June 28th 2014, Jakobsberg, Boppard, Germany
- Cutaneous drug reactions
- A review on: Herbal hair gel preparation and evaluation
- Unexpected hair growth induced by gefitinib treatment in two patients with EGFR gene mutation-positive adenocarcinoma of the lung
- Ponatinib-induced pityriasis rubra pilaris-like adnexal dysmaturation: A case report
- Taiwanese Dermatological Association consensus for the prevention and management of epidermal growth factor receptor tyrosine kinase inhibitor-related skin toxicities
- Natural Sources of Therapeutic Agents Used in Skin Conditions
- Dermatologic adverse events in pediatric patients receiving targeted anticancer therapies: A pooled analysis
- Scalp Pustule as a Manifestation of Erlotinib-Induced Skin Toxicity: Report of Two Cases and Literature Review
- Mucocutaneous findings in hematolymphoid neoplasms: An observational study
- Persistent hair growth during treatment with the EGFR inhibitor erlotinib
- Nelfb promotes dermal white adipose tissue formation through RNA Polymerase II mediated adipogenic gene regulation
- Understanding, recognizing, and managing toxicities of targeted anticancer therapies
- Prevention and management of dermatological toxicities related to anticancer agents: ESMO Clinical Practice Guidelines☆
- Demodicosis in Different Age Groups and Alternative Treatment Options—A Review
- Poster Presentations
- Prophylaxis and Management of Skin Toxicities
- Dermoscopy of skin infestations and infections (entomodermoscopy) – Part I: dermatozoonoses and bacterial infections
- Comparing the frequency of isotretinoin-induced hair loss at <0.5-mg/kg/d versus ≥0.5-mg/kg/d dosing in acne patients: A systematic review
- New Perspectives on Nutraceutical Insulin Sensitizing Agents in the Treatment of Psoriasis and Other Dermatological Diseases
- Cyclin-Dependent Kinase 4/6 Inhibitors and Dermatologic Adverse Events: Results from the EADV Task Force “Dermatology for Cancer Patients” International Study
- Type 2 Diabetes Mellitus and Demodex folliculorum Infestation: A Cross-Sectional Study in Peruvian Patients
- Potential Cosmetic Applications of Dihydroartemisinin
- Cutaneous Adverse Events of Tyrosine Kinase Inhibitors in Endocrine Tumors: Clinical Features, Mechanisms, and Management Strategies
- Skin Manifestations of Rheumatological Diseases